九五至尊网址

GMP-compliant manufacturing

Our ACE Platform also possesses robust in-house manufacturing capability that is compliant with international GMP standards regulated by the NMPA, the FDA and the EMA. which allows us to quickly scale up or switch production between various drug candidates with minimal turnaround time and lower operating cost. We have established nearly four years of successful manufacturing track record by producing our nine internally-developed clinical-stage antibody drug candidates in-house. 

Manufacturing Facilities
Zhongshan Manufacturing Facility

九五至尊网址Our Zhongshan manufacturing facility occupies approximately 3,200 square meters of floor space and currently features 1,700 L of bioreactor capacity. It is estimated to house a total of 3,700 L capacity, as we are in the process of integrating two additional 1,000 L bioreactors to meet our increasing production needs.

Guangzhou Manufacturing Facility

We are building a new manufacturing facility in Guangzhou on a piece of land of 56,573 square meters that is estimated to house up to a total of 40,000 L bioreactor capacity. This includes the first phase of the construction on this land featuring up to eight 2,000 L bioreactors for a total capacity of 16,000 L, which we expect completion of installation and commencement of operation by the end of 2020

www.782.net-最新网址-九五至尊网址 8455娱乐场门新葡8455最新网站-九五至尊网址 357 cc拉斯维加斯3499-九五至尊网址 澳门新莆京98378com-九五至尊网址 澳门太阳集团2007登陆注册-九五至尊网址 新葡京集团 www.350.vip-九五至尊网址 永利402com官方网站手机版-九五至尊网址 澳门新葡亰平台游戏app官网九五至尊网址-九五至尊网址 95992222九五至尊老品牌-九五至尊网址 mg4155娱乐电子游戏官网-九五至尊网址 伟德betvictot手机版-九五至尊网址 188金宝搏亚洲体育app下载-九五至尊网址 vnsc5858威尼斯城官网-九五至尊网址 188金宝搏亚洲体育app-九五至尊网址 澳门威尼斯人官方网投电子游戏-九五至尊网址 js55658澳门金金沙平台-九五至尊网址 亚洲城vipca88手机版登陆-九五至尊网址 williamhill-九五至尊网址 澳门新葡350vip最新网站-九五至尊网址 95998888九五至尊在线-九五至尊网址